BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 28289855)

  • 1. Whole-body MRI, dynamic contrast-enhanced MRI, and diffusion-weighted imaging for the staging of multiple myeloma.
    Dutoit JC; Verstraete KL
    Skeletal Radiol; 2017 Jun; 46(6):733-750. PubMed ID: 28289855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of diffusion-weighted imaging and dynamic contrast-enhanced MRI for multiple myeloma and its precursors (monoclonal gammopathy of undetermined significance and smouldering myeloma).
    Van Den Berghe T; Verstraete KL; Lecouvet FE; Lejoly M; Dutoit J
    Skeletal Radiol; 2022 Jan; 51(1):101-122. PubMed ID: 34523007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined evaluation of conventional MRI, dynamic contrast-enhanced MRI and diffusion weighted imaging for response evaluation of patients with multiple myeloma.
    Dutoit JC; Claus E; Offner F; Noens L; Delanghe J; Verstraete KL
    Eur J Radiol; 2016 Feb; 85(2):373-82. PubMed ID: 26781143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-treatment staging of multiple myeloma patients: comparison of whole-body diffusion weighted imaging with whole-body T1-weighted contrast-enhanced imaging.
    Squillaci E; Bolacchi F; Altobelli S; Franceschini L; Bergamini A; Cantonetti M; Simonetti G
    Acta Radiol; 2015 Jun; 56(6):733-8. PubMed ID: 24973257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of whole-body diffusion-weighted magnetic resonance imaging for the diagnosis of and therapeutic response in multiple myeloma].
    Puskás T; Henits I
    Orv Hetil; 2014 Aug; 155(31):1241-5. PubMed ID: 25095285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Whole body functional MR imaging: hemato-oncologic applications].
    Luciani A; Lin C; Beaussart P; Zerbib P; Haioun C; Rahmouni A
    J Radiol; 2010 Mar; 91(3 Pt 2):375-80. PubMed ID: 20508572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma.
    Dutoit JC; Vanderkerken MA; Verstraete KL
    Eur J Radiol; 2013 Sep; 82(9):1444-52. PubMed ID: 23726124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apparent diffusion coefficient maps integrated in whole-body MRI examination for the evaluation of tumor response to chemotherapy in patients with multiple myeloma.
    Bonaffini PA; Ippolito D; Casiraghi A; Besostri V; Franzesi CT; Sironi S
    Acad Radiol; 2015 Sep; 22(9):1163-71. PubMed ID: 26182979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of whole-body MRI for treatment response assessment in multiple myeloma: comparison between clinical response and imaging response.
    Park HY; Kim KW; Yoon MA; Lee MH; Chae EJ; Lee JH; Chung HW; Yoon DH
    Cancer Imaging; 2020 Jan; 20(1):14. PubMed ID: 32000858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body MRI to assess bone involvement in prostate cancer and multiple myeloma: comparison of the diagnostic accuracies of the T1, short tau inversion recovery (STIR), and high b-values diffusion-weighted imaging (DWI) sequences.
    Larbi A; Omoumi P; Pasoglou V; Michoux N; Triqueneaux P; Tombal B; Cyteval C; Lecouvet FE
    Eur Radiol; 2019 Aug; 29(8):4503-4513. PubMed ID: 30413957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of whole-body diffusion MRI and conventional radiological assessment in the staging of myeloma.
    Narquin S; Ingrand P; Azais I; Delwail V; Vialle R; Boucebci S; Tasu JP
    Diagn Interv Imaging; 2013 Jun; 94(6):629-36. PubMed ID: 23683788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pictorial review of whole body MRI in myeloma: emphasis on diffusion-weighted imaging.
    Hameed M; Sandhu A; Soneji N; Amiras D; Rockall A; Messiou C; Wallitt K; Barwick TD
    Br J Radiol; 2020 Nov; 93(1115):20200312. PubMed ID: 32667830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma.
    Hur J; Yoon CS; Ryu YH; Yun MJ; Suh JS
    Acta Radiol; 2008 May; 49(4):427-35. PubMed ID: 18415787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing extracranial tumors using diffusion-weighted whole-body MRI.
    Lenz C; Klarhöfer M; Scheffler K; Winter L; Sommer G
    Z Med Phys; 2011 May; 21(2):79-90. PubMed ID: 20888200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of MRI for the diagnosis and prognosis of multiple myeloma.
    Baur-Melnyk A; Buhmann S; Dürr HR; Reiser M
    Eur J Radiol; 2005 Jul; 55(1):56-63. PubMed ID: 15950101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparison of Different Staging Systems for Multiple Myeloma: Can the MRI Pattern Play a Prognostic Role?
    Filonzi G; Mancuso K; Zamagni E; Nanni C; Spinnato P; Cavo M; Fanti S; Salizzoni E; Bazzocchi A
    AJR Am J Roentgenol; 2017 Jul; 209(1):152-158. PubMed ID: 28418695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-body MRI for the staging and follow-up of patients with metastasis.
    Schmidt GP; Reiser MF; Baur-Melnyk A
    Eur J Radiol; 2009 Jun; 70(3):393-400. PubMed ID: 19457631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-body MRI of multiple myeloma: comparison of different MRI sequences in assessment of different growth patterns.
    Weininger M; Lauterbach B; Knop S; Pabst T; Kenn W; Hahn D; Beissert M
    Eur J Radiol; 2009 Feb; 69(2):339-45. PubMed ID: 18096344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current concepts in tumor imaging with whole-body MRI with diffusion imaging (WB-MRI-DWI) in multiple myeloma and lymphoma.
    Stecco A; Buemi F; Iannessi A; Carriero A; Gallamini A
    Leuk Lymphoma; 2018 Nov; 59(11):2546-2556. PubMed ID: 29431555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.